(Q46520634)

22 December 2017

title

Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus (English)

1 reference

22 December 2017

0 references

1 reference

4

1 reference

22 December 2017

author name string

Dean T Eurich

series ordinal

1

1 reference

22 December 2017

Scot H Simpson

series ordinal

2

1 reference

22 December 2017

Sumit R Majumdar

series ordinal

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

22 December 2017

published in

Pharmacotherapy

1 reference

22 December 2017

volume

25

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

810-816

1 reference

22 December 2017

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Five stages of evolving beta-cell dysfunction during progression to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Utilization of oral hypoglycemic agents in a drug-insured U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Assessing compliance to antihypertensive medications using computer-based pharmacy records.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

The assessment of refill compliance using pharmacy records: methods, validity, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Replicating the chronic disease score (CDS) from automated pharmacy data

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

A chronic disease score from automated pharmacy data

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

21 January 2018

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Reduced Mortality Associated With the Use of ACE Inhibitors in Patients With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.6.810

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.7326/0003-4819-141-6-200409210-00007

Identifiers

DOI

10.1592/PHCO.2005.25.6.810

1 reference

22 December 2017

PubMed ID

15927899

1 reference

22 December 2017